0001493152-22-027028.txt : 20220928 0001493152-22-027028.hdr.sgml : 20220928 20220928161157 ACCESSION NUMBER: 0001493152-22-027028 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220928 DATE AS OF CHANGE: 20220928 EFFECTIVENESS DATE: 20220928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VBI Vaccines Inc/BC CENTRAL INDEX KEY: 0000764195 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-460161 FILM NUMBER: 221276208 BUSINESS ADDRESS: STREET 1: 160 SECOND STREET STREET 2: CAMBRIDGE CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-830-3031 MAIL ADDRESS: STREET 1: 160 SECOND STREET STREET 2: CAMBRIDGE CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: SciVac Therapeutics Inc. DATE OF NAME CHANGE: 20150717 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD. DATE OF NAME CHANGE: 20100910 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD DATE OF NAME CHANGE: 19850305 D 1 primary_doc.xml X0708 D LIVE 0000764195 VBI Vaccines Inc/BC 160 SECOND STREET FLOOR 3 CAMBRIDGE MA MASSACHUSETTS 02142 (617) 830-3031 BRITISH COLUMBIA, CANADA Levon Resources Ltd. New Congress Resources Ltd. SciVac Therapeutics Inc. LEVON RESOURCES LTD. LEVON RESOURCES LTD Corporation true Jeffrey R. Baxter 160 Second Street Floor 3 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director President, Chief Executive Officer and Director Christopher McNulty 160 Second Street Floor 3 Cambridge MA MASSACHUSETTS 02142 Executive Officer Chief Financial Officer and Head of Business Development Steven Gillis 160 Second Street Floor 3 Cambridge MA MASSACHUSETTS 02142 Director Damian Braga 160 Second Street Floor 3 Cambridge MA MASSACHUSETTS 02142 Director Joanne Cordeiro 160 Second Street Floor 3 Cambridge MA MASSACHUSETTS 02142 Director Michel De Wilde 160 Second Street Floor 3 Cambridge MA MASSACHUSETTS 02142 Director Blaine McKee 160 Second Street Floor 3 Cambridge MA MASSACHUSETTS 02142 Director Pharmaceuticals Decline to Disclose 06b false 2022-09-14 false true true true false 0 0 0 0 Company's lenders may convert $7mil of certain loans to the Company into 6,161,889 shares and may exercise a warrant for 2,180,413 shares. Lenders may make additional loans, entitling them to exercise the warrant for up to an additional 2,180,413 shares. false 1 0 0 0 false VBI Vaccines Inc/BC /s/ Jeffrey R. Baxter Jeffrey R. Baxter President, Chief Executive Officer and Director 2022-09-28